Recent progress toward the use of circulating microRNAs as clinical biomarkers

[1]  C. Robinson-Cohen,et al.  Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Andreas Trumpp,et al.  Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis. , 2016, Carcinogenesis.

[3]  G. Nickenig,et al.  Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus , 2016, Cardiovascular Diabetology.

[4]  Klaus Pantel,et al.  Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer , 2016, Oncotarget.

[5]  R. Urquhart,et al.  Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients , 2016, PloS one.

[6]  Chen-Yu Zhang,et al.  Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus , 2016, Scientific Reports.

[7]  G. Berchem,et al.  Assessing cellular and circulating miRNA recovery: the impact of the RNA isolation method and the quantity of input material , 2016, Scientific Reports.

[8]  Y. Wang,et al.  Plasma extracellular RNA profiles in healthy and cancer patients , 2016, Scientific Reports.

[9]  P. Ashton-Prolla,et al.  miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma , 2016, Pancreas.

[10]  D. Galetta,et al.  miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome , 2016, Tumor Biology.

[11]  P. Dargan,et al.  Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury , 2015, Scientific Reports.

[12]  M. Mayr,et al.  Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes , 2015, Diabetes.

[13]  Taek-Kyun Kim,et al.  Current State of Circulating MicroRNAs as Cancer Biomarkers. , 2015, Clinical chemistry.

[14]  Eduardo Andrés-León,et al.  Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection. , 2015, Clinical chemistry.

[15]  Alissa M. Weaver,et al.  KRAS-dependent sorting of miRNA to exosomes , 2015, eLife.

[16]  D. Galas,et al.  Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes , 2015, Journal of clinical medicine.

[17]  M. Pavkovic,et al.  Glomerulonephritis-Induced Changes in Urinary and Kidney MicroRNA Profiles in Rats. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  Jagmeet P. Singh,et al.  Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study , 2015, Circulation.

[19]  P. Brennan,et al.  Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer , 2015, PloS one.

[20]  A. Krolewski,et al.  Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes , 2015, Diabetes.

[21]  Nilesh J Samani,et al.  MicroRNAs in cardiovascular disease: an introduction for clinicians , 2015, Heart.

[22]  T. Uehara,et al.  Plasma miR‐208 as a useful biomarker for drug‐induced cardiotoxicity in rats , 2015, Journal of applied toxicology : JAT.

[23]  F. B. Sørensen,et al.  Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer , 2015, British Journal of Cancer.

[24]  N. Tanaka,et al.  Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer , 2014, International journal of oncology.

[25]  A. Baccarelli,et al.  Microvesicle-associated microRNA expression is altered upon particulate matter exposure in healthy workers and in A549 cells , 2014, Journal of applied toxicology : JAT.

[26]  Delin Liu,et al.  Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis. , 2015, Cancer biomarkers : section A of Disease markers.

[27]  L. Maegdefessel,et al.  The emerging role of microRNAs in cardiovascular disease , 2014, Journal of internal medicine.

[28]  Qinghuai Liu,et al.  Serum MiRNA Biomarkers serve as a Fingerprint for Proliferative Diabetic Retinopathy , 2014, Cellular Physiology and Biochemistry.

[29]  Yuan He,et al.  Molecular Sciences Circulating Microrna-19a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction , 2022 .

[30]  M. Korc,et al.  A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile , 2014, The American Journal of Gastroenterology.

[31]  Qiulan Chen,et al.  Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer , 2014, Medical Oncology.

[32]  A. Unami,et al.  Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats. , 2014, Toxicology.

[33]  M. Pavkovic,et al.  Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury. , 2014, Toxicology.

[34]  B. Ylstra,et al.  Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. , 2014, Cell reports.

[35]  S. Sen,et al.  Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer , 2014, Journal of Cancer.

[36]  T. Tuschl,et al.  Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers , 2014, Proceedings of the National Academy of Sciences.

[37]  R. Baumgartner,et al.  Smoking alters circulating plasma microvesicle pattern and microRNA signatures , 2014, Thrombosis and Haemostasis.

[38]  W. Cho,et al.  Application of microRNAs in diabetes mellitus. , 2014, The Journal of endocrinology.

[39]  D. Fischer,et al.  Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. , 2014, The Journal of clinical endocrinology and metabolism.

[40]  Xiaofeng Jiang,et al.  The Role of Circulating MicroRNA-126 (miR-126): A Novel Biomarker for Screening Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus , 2014, International journal of molecular sciences.

[41]  Naoto Tsuchiya,et al.  Circulating Exosomal microRNAs as Biomarkers of Colon Cancer , 2014, PloS one.

[42]  F. Hu,et al.  Circulating MicroRNAs and the Occurrence of Acute Myocardial Infarction in Chinese Populations , 2014, Circulation. Cardiovascular genetics.

[43]  Y. Xi,et al.  MiR-200, a new star miRNA in human cancer. , 2014, Cancer letters.

[44]  C. Jingqiu,et al.  Circulating miRNAs might be promising biomarkers to reflect the dynamic pathological changes in smoking-related interstitial fibrosis , 2014, Toxicology and industrial health.

[45]  Ziyuan Zhao,et al.  Dysregulated miR1254 and miR579 for cardiotoxicity in patients treated with bevacizumab in colorectal cancer , 2014, Tumor Biology.

[46]  Sophie Rome,et al.  Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin Sensitization , 2014, Diabetes Care.

[47]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[48]  S. Bojesen,et al.  MicroRNA biomarkers in whole blood for detection of pancreatic cancer. , 2013, JAMA.

[49]  V. Kim,et al.  Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.

[50]  Rounak Nassirpour,et al.  Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms , 2014, BMC Genomics.

[51]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[52]  M. Martínez-Larrad,et al.  Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers , 2013, PloS one.

[53]  T. Fukami,et al.  Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects. , 2013, Toxicology and applied pharmacology.

[54]  V. Cameron,et al.  Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients , 2013, European journal of heart failure.

[55]  Zhang Liping,et al.  Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury , 2013, PloS one.

[56]  F. Hu,et al.  Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus , 2013, PloS one.

[57]  R. Regazzi,et al.  Circulating microRNAs as novel biomarkers for diabetes mellitus , 2013, Nature Reviews Endocrinology.

[58]  Daniela Wenzel,et al.  Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles , 2013, Circulation.

[59]  R. Testa,et al.  Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. , 2013, International journal of cardiology.

[60]  Jasmin Wagner,et al.  Characterization of Levels and Cellular Transfer of Circulating Lipoprotein-Bound MicroRNAs , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[61]  C. Pizarro,et al.  MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes. , 2013, Immunobiology.

[62]  J. Moreno-Navarrete,et al.  Targeting the circulating microRNA signature of obesity. , 2013, Clinical chemistry.

[63]  Axel Benner,et al.  Circulating microRNAs in plasma as early detection markers for breast cancer , 2013, International journal of cancer.

[64]  A. Baccarelli,et al.  Integrative Analysis of miRNA and inflammatory gene expression after acute particulate matter exposure. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[65]  Rong Liu,et al.  Alteration of serum miR-206 and miR-133b is associated with lung carcinogenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2013, Toxicology and applied pharmacology.

[66]  J. Smith,et al.  Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction , 2013, BMC Cardiovascular Disorders.

[67]  Cristina Rodríguez-Padilla,et al.  Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers , 2013, Disease markers.

[68]  D. Galas,et al.  Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes , 2013, PloS one.

[69]  Ava Kwong,et al.  Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection , 2013, PloS one.

[70]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[71]  L. Ma,et al.  Circulating microRNAs in plasma as early detection markers for breast cancer: Cuk K, Zucknick M, Heil J, et al (German Cancer Res Ctr (DKFZ), Heidelberg, Germany; Univ Women's Clinic, Heidelberg, Germany; et al) Int J Cancer 132:1602-1612, 2013§ , 2013 .

[72]  Bei Zhang,et al.  The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers , 2013, Tumor Biology.

[73]  Yan Wang,et al.  Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction , 2012, PloS one.

[74]  R. Coffey,et al.  Proteomic Analysis of Exosomes from Mutant KRAS Colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS* , 2012, Molecular & Cellular Proteomics.

[75]  Jiayin Dai,et al.  Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents. , 2012, Environmental science & technology.

[76]  P. Hougaard,et al.  Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression , 2012, Experimental diabetes research.

[77]  Yi Li,et al.  Exosome‐Mediated Transfer of miR‐133b from Multipotent Mesenchymal Stromal Cells to Neural Cells Contributes to Neurite Outgrowth , 2012, Stem cells.

[78]  X. Wang,et al.  Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer , 2012, The Journal of international medical research.

[79]  Achilleas S. Frangakis,et al.  Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.

[80]  F. Azuaje,et al.  Use of circulating microRNAs to diagnose acute myocardial infarction. , 2012, Clinical chemistry.

[81]  Xi Chen,et al.  Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. , 2012, Clinical chemistry.

[82]  Offer Amir,et al.  Serum levels of microRNAs in patients with heart failure , 2012, European journal of heart failure.

[83]  Longgui Wang,et al.  Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. , 2012, Cancer epidemiology.

[84]  M. Cieśla,et al.  Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. , 2012, Antioxidants & redox signaling.

[85]  Xiao-guang Liu,et al.  High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer , 2012, Medical Oncology.

[86]  Ignace Vergote,et al.  Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers , 2012, Breast Cancer Research.

[87]  W. De,et al.  Prognostic significance of serum miRNA‐21 expression in human non‐small cell lung cancer , 2011, Journal of surgical oncology.

[88]  Jonathan Moggs,et al.  Circulating microRNAs as potential markers of human drug‐induced liver injury , 2011, Hepatology.

[89]  D. Ichikawa,et al.  Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer , 2011, British Journal of Cancer.

[90]  S. Fichtlscherer,et al.  Transcoronary Concentration Gradients of Circulating MicroRNAs , 2011, Circulation.

[91]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[92]  Patrick Maisonneuve,et al.  A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer , 2011, EMBO molecular medicine.

[93]  Danish Sayed,et al.  MicroRNAs in development and disease. , 2011, Physiological reviews.

[94]  B. Burwinkel,et al.  Characterization of extracellular circulating microRNA , 2011, Nucleic acids research.

[95]  E. Lai,et al.  Vive la différence: biogenesis and evolution of microRNAs in plants and animals , 2011, Genome Biology.

[96]  B. Jiang,et al.  MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression , 2011, PloS one.

[97]  M. Nykter,et al.  Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis , 2011, PloS one.

[98]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[99]  Ugo Pastorino,et al.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.

[100]  V. Mohan,et al.  Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes , 2011, Molecular and Cellular Biochemistry.

[101]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[102]  Feng Jiang,et al.  Plasma microRNAs as potential biomarkers for non-small-cell lung cancer , 2010, Laboratory Investigation.

[103]  Yong Huang,et al.  Biological functions of microRNAs: a review , 2011, Journal of Physiology and Biochemistry.

[104]  Y. Gong,et al.  Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis , 2011, Digestive Diseases and Sciences.

[105]  Min Xu,et al.  Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study , 2011, Acta Diabetologica.

[106]  Jan A Staessen,et al.  Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.

[107]  Yue Wang,et al.  Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. , 2010, Clinical chemistry.

[108]  AnnaZampetaki,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010 .

[109]  M. Mayr,et al.  Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.

[110]  Jessica A. Weber,et al.  Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.

[111]  Yue Yu,et al.  Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[112]  Zhaohui Huang,et al.  Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.

[113]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[114]  Federica Limana,et al.  Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European heart journal.

[115]  Quynh-Thu Le,et al.  Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. , 2010, Translational oncology.

[116]  Xi Chen,et al.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[117]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[118]  Yue Li,et al.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.

[119]  Robert A. Weinberg,et al.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.

[120]  Hong Peng,et al.  Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. , 2010, Lung cancer.

[121]  G. Hirokawa,et al.  Plasma miR-208 as a biomarker of myocardial injury. , 2009, Clinical chemistry.

[122]  Ann M. Killary,et al.  MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.

[123]  E. Ng,et al.  Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.

[124]  Anna M. Krichevsky,et al.  miR-21: a small multi-faceted RNA , 2008, Journal of cellular and molecular medicine.

[125]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[126]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[127]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[128]  A. Tedgui,et al.  Microparticles and type 2 diabetes. , 2008, Diabetes & metabolism.

[129]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.

[130]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[131]  A. Siriwardena,et al.  Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[132]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[133]  R. Pillai.  MicroRNA function: multiple mechanisms for a tiny RNA? , 2005, RNA.

[134]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[135]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[136]  E. L. Hess,et al.  The purple color reaction given by diphenylamine reagent. I. With normal and rheumatic fever sera. , 1951, The Journal of clinical investigation.